{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T11:41:44Z","timestamp":1771674104772,"version":"3.50.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>In patients with hypoalbuminemia after craniotomy, total serum concentrations of valproic acid (VPA) may provide poor clinical insights, owing to saturated protein binding and increased unbound fractions. However, very few clinical laboratories routinely analyze free concentrations of the drug. The aim of this study was to develop a model to predict serum-free and cerebrospinal fluid (CSF) levels of VPA based on its total concentration and to investigate the model's applicability.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Total serum and CSF concentrations of VPA in 79 patients were measured using a validated immunoassay between January 2015 and December 2015. The demographic, clinical, and laboratory information of patients were retrieved from medical records. A multiple linear regression analysis was adopted to determine the potential variations and establish the functional relationship between CSF concentration and significant clinical factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Based on the stepwise multiple linear regression analysis performed using the natural logarithm of the concentration of VPA in the CSF as the dependent variable, serum concentrations of VPA (X<jats:sub>1<\/jats:sub>, \u03b2' = 0.844), serum albumin concentration (X<jats:sub>2<\/jats:sub>, \u03b2' = \u22120.393), and CSF protein concentration (X<jats:sub>3<\/jats:sub>, \u03b2' = 0.098) were identified as the 3 variables that significantly predicted the dependent variable: \n                                    \n                                       \n                                          \n                                             JOURNAL\/thdm\/04.03\/00007691-202008000-00014\/inline-formula1\/v\/2023-08-14T203553Z\/r\/image-tiff\n                                          \n                                       \n                                    \n                                 , with a coefficient of determination (R<jats:sup>2<\/jats:sup>) of 0.874. As the CSF protein level is often unavailable, the model was redefined to include 2 variables\u2014serum concentrations of VPA (X<jats:sub>1<\/jats:sub>, \u03b2' = 0.840) and serum albumin concentration (X<jats:sub>2<\/jats:sub>, \u03b2' = \u22120.359): \n                                    \n                                       \n                                          \n                                             JOURNAL\/thdm\/04.03\/00007691-202008000-00014\/inline-formula2\/v\/2023-08-14T203553Z\/r\/image-tiff\n                                          \n                                       \n                                    \n                                 , with R<jats:sup>2<\/jats:sup> = 0.813.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Based on total VPA and serum albumin concentrations, we developed a model to predict serum-free and CSF levels of VPA. This model is useful for correcting dose adjustment in patients with hypoalbuminemia after craniotomy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000000749","type":"journal-article","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T05:19:14Z","timestamp":1582521554000},"page":"610-616","source":"Crossref","is-referenced-by-count":5,"title":["Prediction of Serum-Free and Cerebrospinal Fluid Valproic Acid Levels in Patients With Hypoalbuminemia After Craniotomy"],"prefix":"10.1097","volume":"42","author":[{"given":"Zhihong","family":"Li","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Shanxi Bethune Hospital (Shanxi Academy of Medical Sciences); and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqi","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Shanxi Bethune Hospital (Shanxi Academy of Medical Sciences); and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guifen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Shanxi Bethune Hospital (Shanxi Academy of Medical Sciences); and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/phar.1912","article-title":"Valproate protein binding is highly variable in ICU patients and not predicted by total serum concentrations: a case series and literature review","volume":"37","author":"Riker","year":"2017","journal-title":"Pharmacotherapy."},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00003088-198005010-00002","article-title":"Clinical pharmacokinetics of valproic acid","volume":"5","author":"Gugler","year":"1980","journal-title":"Clin Pharmacokinet."},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1124\/dmd.115.067595","article-title":"Considering age variation when coining drugs as high versus low hepatic extraction ratio","volume":"44","author":"Salem","year":"2016","journal-title":"Drug Metab Dispos."},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"8","DOI":"10.9740\/mhc.2015.01.008","article-title":"Pharmacokinetic characteristics of antiepileptic drugs (AEDs)","volume":"6","author":"Marvanova","year":"2016","journal-title":"Ment Health Clin."},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1515\/CCLM.2002.172","article-title":"Clinical utility of free drug monitoring","volume":"40","author":"Dasgupta","year":"2002","journal-title":"Clin Chem Lab Med."},{"key":"R6-20230814","first-page":"5","article-title":"Clinical significance of drug binding, protein binding, and binding displacement drug interactions","volume":"36","author":"DeVane","year":"2002","journal-title":"Psychopharmacol Bull."},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/B978-0-12-385467-4.00004-X","article-title":"Clinical utility of free drug monitoring. In","author":"Musteata","year":"2012","journal-title":"Therapeutic Drug Monitoring: Newer Drugs and Biomarkers"},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1345\/aph.1P308","article-title":"High unbound fraction of valproic acid in a hypoalbuminemic critically ill patient on renal replacement therapy","volume":"45","author":"de Maat","year":"2011","journal-title":"Ann Pharmacother."},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1345\/aph.19147","article-title":"Elevated free fractions of valproic acid in a heart transplant patient with hypoalbuminemia","volume":"34","author":"Haroldson","year":"2000","journal-title":"Ann Pharmacother."},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/FTD.0000000000000405","article-title":"Monitoring protein-unbound Valproic acid serum concentrations in clinical practice","volume":"39","author":"Wallenburg","year":"2017","journal-title":"Ther Drug Monit."},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2006.08.026","article-title":"Usefulness of monitoring free (unbound) concentrations of therapeutic drugs in patient management","volume":"377","author":"Dasgupta","year":"2007","journal-title":"Clin Chim Acta."},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/phar.1965","article-title":"Clinical importance of monitoring unbound valproic acid concentration in patients with hypoalbuminemia","volume":"37","author":"Dor\u00e9","year":"2017","journal-title":"Pharmacotherapy."},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.4155\/bio.11.187","article-title":"Monitoring free drug concentrations: challenges","volume":"3","author":"Musteata","year":"2011","journal-title":"Bioanalysis."},{"key":"R14-20230814","first-page":"25","article-title":"Pharmacokinetics, drug interactions, and tolerability of valproate","volume":"37","author":"DeVane","year":"2003","journal-title":"Psychopharmacol Bull."},{"key":"R15-20230814","first-page":"649","article-title":"Valproic acid: a simple method for the estimation of free serum concentration","volume":"51","author":"Parent","year":"1993","journal-title":"Ann Biol Clin."},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1254\/jphs.FPE04007X","article-title":"A theoretical method for normalizing total serum valproic acid concentration in hypoalbuminemic patients","volume":"97","author":"Hermida","year":"2005","journal-title":"J Pharmacol Sci."},{"key":"R17-20230814","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1124\/dmd.109.026674","article-title":"Unbound brain concentration determines receptor occupancy: a correlation of drug concentration and brain serotonin and dopamine reuptake transporter occupancy for eighteen compounds in rats","volume":"37","author":"Liu","year":"2009","journal-title":"Drug Metab Dispos."},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1080\/01616412.2016.1173324","article-title":"Organic anion transporting polypeptide 2 transports valproic acid in rat brain microvascular endothelial cells","volume":"38","author":"Guo","year":"2016","journal-title":"Neurol Res."},{"key":"R19-20230814","first-page":"1","article-title":"Valproic acid. In","author":"Snodgrass","year":"2015","journal-title":"Critical Care Toxicology"},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2125.1983.tb02179.x","article-title":"Plasma protein-binding and CSF concentrations of valproic acid in man following acute oral dosing","volume":"16","author":"Rapeport","year":"1983","journal-title":"Br J Clin Pharmacol."},{"key":"R21-20230814","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1248\/bpb.23.784","article-title":"Pharmacokinetics of cytosine arabinoside, methotrexate, nimustine and valproic acid in cerebrospinal fluid during cerebrospinal fluid perfusion chemotherapy","volume":"23","author":"Morikawa","year":"2000","journal-title":"Biol Pharm Bull."},{"key":"R22-20230814","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/106002809302700107","article-title":"Apparent valproic acid neurotoxicity in a hypoalbuminemic patient","volume":"27","author":"Gidal","year":"1993","journal-title":"Ann Pharmacother."},{"key":"R23-20230814","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12028-018-0627-4","article-title":"Accuracy of valproic acid concentration correction based on serum albumin","volume":"30","author":"Drisaldi","year":"2019","journal-title":"Neurocrit Care."},{"key":"R24-20230814","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/clinchem\/44.5.1085","article-title":"Standards of laboratory practice: antiepileptic drug monitoring","volume":"44","author":"Warner","year":"1998","journal-title":"Clin Chem."},{"key":"R25-20230814","first-page":"92","article-title":"Individualized dosage adjustment of valproic acid based on unbound serum concentration in intractable epileptic children","volume":"128","author":"Ueshima","year":"2008","journal-title":"Yakugaku Zasshi-J Pharm Soc Jpn."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T22:25:25Z","timestamp":1692051925000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000749","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]}}}